Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

Healthcare has become the second-best performer in the S&P 500 (SP500) this month, prompting market observers to foresee a brighter 2025 for a sector that has struggled to outperform the broader index ...

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.